StarZero All shows Try the podcast clipper →

Nico Wittenborn

Founder & Solo GP, Adjacent · 2 appearances on the record.

computed by AI from the episodes · how this works → · full disclaimer →

investorfounder@ncsh ↗adjacent.com ↗

Nico Wittenborn is an early-stage tech investor known for pioneering the solo GP model with his fund Adjacent, which focuses on mobile-first consumer subscription apps and software. Prior to Adjacent, he invested at Point Nine Capital and Insight Partners, backing companies including Photoroom, Calm, Oura, Revolut, and RevenueCat.

49statements → 16claims → 9claims resolved → 56%fully supported → 3.86/5average certainty → 2.16/5average debate potential → 4.0/5argument clarity · the sources → 18said about them ↓

5 supported 4 partly supported 0 contradicted 7 not checkable as stated how the 16 claims stand · each chip opens the sources

6 predictions · 10 assertions · 3 opinions · 19 insights · 11 disclosures · every statement was checked. The predictions and assertions are the 16 claims: statements the public record can support or contradict. 9 are resolved, and 7 name no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.

The record, in short

What the tape says about how Nico argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.

Their most notable supported claim

Prediction Held up
Wittenborn: Venture capital fund sizes will shrink in coming years
“It's certainly hard to make a blanket statement, but I think that fund sizes will go down.”
Nico Wittenborn May 22, 2023 ▶ 1:00:57 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings

Expressed certainty vs assessment result

none yet certainty 1
none yet certainty 2
100% certainty 3
80% certainty 4
50% certainty 5

weighted support: a fully supported claim counts one, a partly supported claim counts half. Each filled bar is clickable and opens exactly those claims; "none yet" means nothing said at that certainty level has resolved yet

Argument clarity: do they answer the question? how? →

4.0 / 5 directness 4 · coherence 4.2 · precision 3.7 · compression 3.4

redirected or did not address 3 of 34 assessed questions (9%). Watch them ▸

This is a score against a rubric. It is not a rank. Every host question → answer exchange is scored with names hidden on directness, coherence, precision and compression, 1–5 each, on meaning alone: disfluencies are ignored, and only raw unedited episodes count. This is the score that measures thought. Every scored exchange, scores shown → · The rubric and its checks →

How they sound: speaking style how? →

271 words/min while actually speaking · 22.3 um and uh per 1k words · 20.3 false starts per 1k · 38.2% of pauses land inside a clause

English is their second language (first language: German). These numbers measure fluency in English. They do not measure thought; the argument clarity score above is read from substance alone.

Measured by listening to the audio itself: 17,992 words across 2 episodes of raw-level tape, transcribed verbatim with every um and uh kept, each one attributed only where the alignment onto our timed stream is unambiguous. These are measurements of speaking style. We do not rank them: across this corpus, fluency and argument quality are nearly uncorrelated (ρ≈0.2), and smooth talking does not signal clear thinking. How it's measured →

How the interview went all their pushback → series average →

Across 2 rated episodes:

host pushback ▾ 2/10
pushed back at the host ▾ 1.5/10
setup questions received 45%

Everything Nico Wittenborn said on 20VC that made the record, most notable first. Filter by type, assessment or year in the ledger →

Insight
Wittenborn: Macro growth drivers matter far more than execution
“And so I believe that those companies benefit from growth drivers that are much more meaningful than any execution.”
Nico Wittenborn May 22, 2023 ▶ 57:31 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Assertion Not checkable as stated
Wittenborn: The US has a higher caliber of venture investors than Europe
“That being said, I've met many more investors that I'm impressed with in the U.S. Than in Europe, right?”
Nico Wittenborn May 22, 2023 ▶ 1:06:30 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Insight
Wittenborn: Paywall display frequency is top driver of subscription conversion
“And so what Superwall is doing is optimizing paywalls. And so one of the learnings that we have from that is that the number one indicator for driving conversion is how often do you see the paywall, right?”
Nico Wittenborn May 22, 2023 ▶ 20:44 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Opinion
Wittenborn: VCs Dislike Consumer Subscription Until Tens of Millions in Revenue
“Because people don't like consumer subscription until it does tens of millions in revenue.”
Nico Wittenborn May 22, 2023 ▶ 32:54 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Prediction Not checkable as stated
Wittenborn: Existing consumer subscription apps will win most value from AI
“The way I think about it from an adjacent perspective is we're going to have companies that are already consumer subscription companies that are implementing this to make their products even more sticky, more functional and give features that were not possible…”
Nico Wittenborn May 22, 2023 ▶ 59:23 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Prediction Held up
Wittenborn: Venture capital fund sizes will shrink in coming years
“It's certainly hard to make a blanket statement, but I think that fund sizes will go down.”
Nico Wittenborn May 22, 2023 ▶ 1:00:57 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Assertion Supported
Wittenborn: Duolingo commands higher revenue multiples than comparable SaaS companies
“There's now a Duolingo that's, I would just want to stress this, in this current macro, they have a much higher multiple on their revenue run rate than comparable SaaS companies.”
Nico Wittenborn May 22, 2023 ▶ 1:07:22 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Assertion Supported
Founders Fund was the only VC to proactively halve its fund size
“Also, they're the only ones that Cut their fund size in half proactively when the macro changed. So they went from, I don't know, 1.8 to nine hundred million in two funds, right?”
Nico Wittenborn May 22, 2023 ▶ 1:18:26 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Assertion Supported
Wittenborn: Consumer subscription apps can reach $1B to $5B outcomes
“So I think that, yes, today, I believe we're early. However, I have enough confidence based on what I've seen that we can get to multi-billion dollar outcomes, right? I don't know about ten billion dollar outcomes, but I think one, two, three, four, five billi…”
Nico Wittenborn May 22, 2023 ▶ 12:29 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Insight
Wittenborn: Consumer App Churn Resembles SMB SaaS After Year One
“The insight that we've had with some of the first companies we invested in is that the churn is usually high in the first year, and then from the second year on, it looks very much like SMB SaaS churn.”
Nico Wittenborn May 22, 2023 ▶ 13:53 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Prediction Not checkable as stated
Wittenborn: Consumer app prices will follow SaaS trajectory over 5-10 years
“The price increases that we have seen since, like, let's say, a corn launch to what it charges yearly today and what it will charge in five to 10 years, I think it has a similar trajectory to what we've seen with SaaS companies and their ability to extract val…”
Nico Wittenborn May 22, 2023 ▶ 19:12 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Assertion Supported
Wittenborn: Seed-stage consumer subscription apps can reach tens of millions in revenue
“Often with a seed round, you get to tens of millions in revenue.”
Nico Wittenborn May 22, 2023 ▶ 23:07 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Prediction Not checkable as stated
Wittenborn: Adjacent Plans for Three-Year Cash Runway in Round Structuring
“At the same time, it enables the founder to have more money so that they have longer runway, which typically now I plan for three years.”
Nico Wittenborn May 22, 2023 ▶ 32:28 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Insight
Wittenborn: Seed-Stage Startups Do Not Need Formal Board Seats
“At Seed, you don't need a board, I think, because you're chasing product market fit, and so most of the time I'm in your way.”
Nico Wittenborn May 22, 2023 ▶ 35:01 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Assertion Partly supported
Point Nine broke its rules to invest in Revolut's seed round
“When I was with .9 and reinvested in Revolut, it was both outside of the focus, right? It's a mobile consumer app. It was actually had just closed the seat round with Balderton. So there was no actionable opportunity and the only way to get in was actually for…”
Nico Wittenborn May 22, 2023 ▶ 44:40 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Insight
Wittenborn: Investment frameworks exist to test conviction when breaking them
“I think that part of the frameworks that we set for ourselves are litmus test for the conviction to break them.”
Nico Wittenborn May 22, 2023 ▶ 45:20 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Insight
Wittenborn: Solo GP model fits early-stage VC better than consensus partnerships
“I think solo GP is, For the right person, a very good fit for the early stage. And I think most consensus driven models at the early stage, unless it's a very aware and mindful partnership that really supports each other and, you know, can all see the complexi…”
Nico Wittenborn May 22, 2023 ▶ 51:00 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Disclosure
Wittenborn: Backed founders who initially aimed for $10M scale
“So I do, like, I've invested in founders that told me, we want to scale to ten million and then we'll see. Right? Like, which nobody else would do that.”
Nico Wittenborn May 22, 2023 ▶ 54:32 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Opinion
Wittenborn: European founders prioritize US venture investors over local funds
“One thing I've actually noticed is that the European founders care about having a US investor.”
Nico Wittenborn May 22, 2023 ▶ 1:05:44 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Insight
Wittenborn: Founders respect VCs who built their own firm over hired partners
“And I think that is something, by the way, that I think founders respect, right? Because you're not an associate or principal, even a partner that was hired into a firm with a cushy salary, but you took a risk, you built something, and you're trying to, you kn…”
Nico Wittenborn May 22, 2023 ▶ 1:10:36 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Insight
Massive user engagement allows early startups to figure out monetization later
“If you can show that this is something people really love, and there's just huge traction in terms of usage or growth, then we think that monetization can often, often follow that.”
Nico Wittenborn Jul 27, 2015 ▶ 11:22 20 VC 057: The Investor Checklist with Nicolas Wittenborn, VC @ Point Nine Capital
Insight
Wittenborn: Tech evolution occurs deterministically through combining existing phenomena
“Evolution happens usually as a combination of the existing phenomena and in a relatively deterministic way.”
Nico Wittenborn May 22, 2023 ▶ 55:31 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Prediction Not checkable as stated
Wittenborn: Adjacent Portfolio Companies Must Pay Back CAC Within One Year
“We steer acquisition so that we recover the CAC with the first year, ok? So every time you get a yearly subscriber that pays back your CAC, you don't overspend”
Nico Wittenborn May 22, 2023 ▶ 15:07 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings
Insight
Wittenborn: Consumer Apps Should Target 50% Organic Customer Acquisition
“The guideline I give is 50%.”
Nico Wittenborn May 22, 2023 ▶ 16:31 Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP's | E1017 · 20VC with Harry Stebbings

Show 24statements(25 left)

The other half of the tape: Nico Wittenborn's own voice is left out of every number here. Other people bring the name up 18 times in 11 episodes on 20VC. every mention, with the transcript →

Who brings them up most Harry Stebbings 14Suchit Dash 2Martin Mignot 2

Every mention by year

tap a year for its mentions
003264201720182019202020212022202320242025episodesmentions
024201720182019202020212022202320242025episodes it came up in
001224201720182019202020212022202320242025episodesmentions per episode
2025 4 mentions in 2 episodes 2 per episode
2024 4 mentions in 2 episodes 2 per episode
2023 6 mentions in 4 episodes 2 per episode
2018 1 mention in 1 episode
2017 3 mentions in 2 episodes 2 per episode

Appearances (2)

EpisodeDateSpeaking time
Nico Wittenborn: Consumer Subscription Apps; Using Evolutionary Biology to Invest; Solo GP May 22, 2023 1h 7m
20 VC 057: The Investor Checklist with Nicolas Wittenborn, VC @ Point Nine Capital Jul 27, 2015 18m
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,200 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more